Report Detail
Global Wet Age-Related Macular Degeneration Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4509625 |
- 13 February, 2023 |
- Global |
- 98 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Wet Age-Related Macular Degeneration Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The most common treatment doctors use to slow vision loss from wet AMD is called anti-VEGF injections. These medicines help stop bleeding and leaking from blood vessels in the back of your eye. Most people with wet AMD will get anti-VEGF injections as their only treatment.
This report is a detailed and comprehensive analysis for global Wet Age-Related Macular Degeneration Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Wet Age-Related Macular Degeneration Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Wet Age-Related Macular Degeneration Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Wet Age-Related Macular Degeneration Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Wet Age-Related Macular Degeneration Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Wet Age-Related Macular Degeneration Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Wet Age-Related Macular Degeneration Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Regeneron Pharmaceuticals, Bayer HealthCare and Kanghong Pharma. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Wet Age-Related Macular Degeneration Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lucentis
Eylea
Avastin
Others
Market segment by Application
Hospital
Clinic
Other
Major players covered
Roche
Novartis
Regeneron Pharmaceuticals
Bayer HealthCare
Kanghong Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Wet Age-Related Macular Degeneration Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Wet Age-Related Macular Degeneration Treatment, with price, sales, revenue and global market share of Wet Age-Related Macular Degeneration Treatment from 2018 to 2023.
Chapter 3, the Wet Age-Related Macular Degeneration Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Wet Age-Related Macular Degeneration Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Wet Age-Related Macular Degeneration Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Wet Age-Related Macular Degeneration Treatment.
Chapter 14 and 15, to describe Wet Age-Related Macular Degeneration Treatment sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Wet Age-Related Macular Degeneration Treatment
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Wet Age-Related Macular Degeneration Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Lucentis
- 1.3.3 Eylea
- 1.3.4 Avastin
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Wet Age-Related Macular Degeneration Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Wet Age-Related Macular Degeneration Treatment Market Size & Forecast
- 1.5.1 Global Wet Age-Related Macular Degeneration Treatment Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Wet Age-Related Macular Degeneration Treatment Sales Quantity (2018-2029)
- 1.5.3 Global Wet Age-Related Macular Degeneration Treatment Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Wet Age-Related Macular Degeneration Treatment Product and Services
- 2.1.4 Roche Wet Age-Related Macular Degeneration Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Novartis
- 2.2.1 Novartis Details
- 2.2.2 Novartis Major Business
- 2.2.3 Novartis Wet Age-Related Macular Degeneration Treatment Product and Services
- 2.2.4 Novartis Wet Age-Related Macular Degeneration Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Novartis Recent Developments/Updates
- 2.3 Regeneron Pharmaceuticals
- 2.3.1 Regeneron Pharmaceuticals Details
- 2.3.2 Regeneron Pharmaceuticals Major Business
- 2.3.3 Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Product and Services
- 2.3.4 Regeneron Pharmaceuticals Wet Age-Related Macular Degeneration Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Regeneron Pharmaceuticals Recent Developments/Updates
- 2.4 Bayer HealthCare
- 2.4.1 Bayer HealthCare Details
- 2.4.2 Bayer HealthCare Major Business
- 2.4.3 Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Product and Services
- 2.4.4 Bayer HealthCare Wet Age-Related Macular Degeneration Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Bayer HealthCare Recent Developments/Updates
- 2.5 Kanghong Pharma
- 2.5.1 Kanghong Pharma Details
- 2.5.2 Kanghong Pharma Major Business
- 2.5.3 Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Product and Services
- 2.5.4 Kanghong Pharma Wet Age-Related Macular Degeneration Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Kanghong Pharma Recent Developments/Updates
3 Competitive Environment: Wet Age-Related Macular Degeneration Treatment by Manufacturer
- 3.1 Global Wet Age-Related Macular Degeneration Treatment Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Wet Age-Related Macular Degeneration Treatment Revenue by Manufacturer (2018-2023)
- 3.3 Global Wet Age-Related Macular Degeneration Treatment Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Wet Age-Related Macular Degeneration Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Wet Age-Related Macular Degeneration Treatment Manufacturer Market Share in 2022
- 3.4.2 Top 6 Wet Age-Related Macular Degeneration Treatment Manufacturer Market Share in 2022
- 3.5 Wet Age-Related Macular Degeneration Treatment Market: Overall Company Footprint Analysis
- 3.5.1 Wet Age-Related Macular Degeneration Treatment Market: Region Footprint
- 3.5.2 Wet Age-Related Macular Degeneration Treatment Market: Company Product Type Footprint
- 3.5.3 Wet Age-Related Macular Degeneration Treatment Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Wet Age-Related Macular Degeneration Treatment Market Size by Region
- 4.1.1 Global Wet Age-Related Macular Degeneration Treatment Sales Quantity by Region (2018-2029)
- 4.1.2 Global Wet Age-Related Macular Degeneration Treatment Consumption Value by Region (2018-2029)
- 4.1.3 Global Wet Age-Related Macular Degeneration Treatment Average Price by Region (2018-2029)
- 4.2 North America Wet Age-Related Macular Degeneration Treatment Consumption Value (2018-2029)
- 4.3 Europe Wet Age-Related Macular Degeneration Treatment Consumption Value (2018-2029)
- 4.4 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Consumption Value (2018-2029)
- 4.5 South America Wet Age-Related Macular Degeneration Treatment Consumption Value (2018-2029)
- 4.6 Middle East and Africa Wet Age-Related Macular Degeneration Treatment Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 5.2 Global Wet Age-Related Macular Degeneration Treatment Consumption Value by Type (2018-2029)
- 5.3 Global Wet Age-Related Macular Degeneration Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 6.2 Global Wet Age-Related Macular Degeneration Treatment Consumption Value by Application (2018-2029)
- 6.3 Global Wet Age-Related Macular Degeneration Treatment Average Price by Application (2018-2029)
7 North America
- 7.1 North America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 7.2 North America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 7.3 North America Wet Age-Related Macular Degeneration Treatment Market Size by Country
- 7.3.1 North America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Country (2018-2029)
- 7.3.2 North America Wet Age-Related Macular Degeneration Treatment Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 8.2 Europe Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 8.3 Europe Wet Age-Related Macular Degeneration Treatment Market Size by Country
- 8.3.1 Europe Wet Age-Related Macular Degeneration Treatment Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Wet Age-Related Macular Degeneration Treatment Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Market Size by Region
- 9.3.1 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Wet Age-Related Macular Degeneration Treatment Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 10.2 South America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 10.3 South America Wet Age-Related Macular Degeneration Treatment Market Size by Country
- 10.3.1 South America Wet Age-Related Macular Degeneration Treatment Sales Quantity by Country (2018-2029)
- 10.3.2 South America Wet Age-Related Macular Degeneration Treatment Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Wet Age-Related Macular Degeneration Treatment Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Wet Age-Related Macular Degeneration Treatment Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Wet Age-Related Macular Degeneration Treatment Market Size by Country
- 11.3.1 Middle East & Africa Wet Age-Related Macular Degeneration Treatment Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Wet Age-Related Macular Degeneration Treatment Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Wet Age-Related Macular Degeneration Treatment Market Drivers
- 12.2 Wet Age-Related Macular Degeneration Treatment Market Restraints
- 12.3 Wet Age-Related Macular Degeneration Treatment Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Wet Age-Related Macular Degeneration Treatment and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Wet Age-Related Macular Degeneration Treatment
- 13.3 Wet Age-Related Macular Degeneration Treatment Production Process
- 13.4 Wet Age-Related Macular Degeneration Treatment Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Wet Age-Related Macular Degeneration Treatment Typical Distributors
- 14.3 Wet Age-Related Macular Degeneration Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Wet Age-Related Macular Degeneration Treatment. Industry analysis & Market Report on Wet Age-Related Macular Degeneration Treatment is a syndicated market report, published as Global Wet Age-Related Macular Degeneration Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Wet Age-Related Macular Degeneration Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
